Search

Researchers at University Hospital in Sonderborg, Denmark, have developed a new physiotherapist-coordinated interdisciplinary rehabilitation intervention for individuals suspected of axial spondyloarthritis. This intervention, part of the SPINCODE project, aims to provide early diagnosis and treatment for people with this condition. The six-month rehabilitation program includes individual consultations, group sessions, and optional support from an interdisciplinary team, and is now ready for feasibility testing. For more information, readers can refer to the Journal of Clinical Medicine. [Extracted from the article]

A recent study from Rome, Italy, explores the impact of lifestyle factors such as smoking, alcohol consumption, and unhealthy diet on the progression and management of Spondyloarthritis (SpA), a group of chronic inflammatory diseases affecting the spine and joints. The research emphasizes the importance of personalized lifestyle changes in conjunction with conventional therapies for optimal disease control and improved outcomes. Healthcare providers are encouraged to support patients in making these personalized lifestyle modifications to enhance SpA management. [Extracted from the article]

A study conducted at the Chinese University of Hong Kong evaluated the performance of proposed cut-offs from the Assessment of Spondyloarthritis International Society (ASAS) in distinguishing axial involvement in patients with psoriatic arthritis (PsA). The study included 72 PsA patients and found that the proposed cut-offs for active and structural lesions of the sacroiliac joint (SIJ) demonstrated satisfactory performance in discriminating axial involvement in PsA patients. The research concluded that incorporating MRI spine lesions did not significantly change sensitivity or specificity compared to assessing SIJ alone. The study was published in the Journal of Clinical Rheumatology and Immunology. [Extracted from the article]

A recent study conducted at Rigshospitalet focused on the recording practices of non-musculoskeletal manifestations, comorbidities, and safety outcomes in European spondyloarthritis registries. The research aimed to identify data collection practices across 17 registries to inform treatment strategies for patients with psoriatic arthritis and axial spondyloarthritis. Findings revealed that a wide range of conditions were consistently recorded across the registries, supporting the potential for future collaborative research in this field. The study emphasizes the importance of international collaboration to enhance generalizability and statistical power in understanding these conditions. [Extracted from the article]

Researchers from the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou, China, have developed a guideline for selecting biomarkers in the diagnosis and assessment of axial spondyloarthritis (axSpA). The guideline includes 20 recommendations, with two strong recommendations for HLA-B27 testing and regular monitoring of CRP/ESR. The researchers emphasize that clinical decisions should consider factors such as costs, accessibility, patient values, and the local context. This guideline aims to provide healthcare professionals with a clinical toolkit for choosing biomarkers in axSpA diagnosis and evaluation. [Extracted from the article]

A recent study conducted at Bursa Uludag University focused on translating and validating the Spondyloarthritis Knowledge Questionnaire (SPAKE) into Turkish to assess the knowledge level of patients with spondyloarthritis (SpA). The study, which included 226 SpA patients, found that the Turkish version of SPAKE (SPAKE-T) demonstrated satisfactory psychometric properties in terms of validity and reliability. The researchers concluded that SPAKE-T can effectively evaluate patients' knowledge about disease self-management. For more information, the full article can be accessed in the European Journal of Rheumatology. [Extracted from the article]

A new study from Leiden University Medical Center in the Netherlands examines the sensitivity to change in structural imaging outcomes over a 10-year period in patients with axial spondyloarthritis (axSpA). The study found that MRI structural outcomes in the sacroiliac joints (SIJ) were more sensitive to change than radiographic outcomes. However, the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) remained the most sensitive method for assessing changes in the spine. The research provides valuable insights into the evaluation of musculoskeletal diseases and conditions. [Extracted from the article]

A recent study conducted at Leiden University Medical Center in the Netherlands compared the health-related quality of life (HRQoL) and work productivity of patients with axial spondyloarthritis (axSpA) and non-axial spondyloarthritis. The study found that non-axSpA patients had worse HRQoL and work productivity at baseline compared to axSpA patients. However, after two years, both groups showed improvements in HRQoL and work productivity, with axSpA patients experiencing larger improvements. This research provides valuable insights into the impact of these conditions on patients' lives and highlights the importance of early intervention and treatment. [Extracted from the article]

A recent study conducted at the University Hospital in Krakow, Poland, explored the knowledge and perceptions of patients with axial spondyloarthritis (AxSpA) regarding their diagnosis and management. The study found that many AxSpA patients experience diagnostic delays and have poor patient-physician communication, leading to inadequate awareness and delayed treatment. Additionally, the majority of patients reported barriers to maintaining an active lifestyle, such as pain, fatigue, lack of motivation, and lack of time. The study suggests that addressing these barriers through personalized, motivational, and educational strategies could improve patient outcomes. [Extracted from the article]

A recent study conducted at the University of Bath in the United Kingdom focused on fatigue patterns in patients with axial spondyloarthritis (axSpA). Fatigue is a common and debilitating symptom for these patients, particularly during flares. The study aimed to determine if there were significant differences in fatigue scores depending on patients' self-reported flare status. The results showed that fatigue was highest during the middle of a flare, compared to the start or end of a flare or the day before a flare. This research could help refine interventions to minimize the impact of fatigue in axSpA patients. [Extracted from the article]

A study conducted at Ipswich Hospital in the United Kingdom aimed to improve the time to diagnosis for axial spondyloarthritis (axSpA), a condition with a long average diagnosis time of 8.3 years. The hospital established an axSpA service from scratch, developed referral pathways, and provided education on axSpA. The study found that the waiting time from initial presentation to diagnosis in rheumatology decreased from 29 weeks to 13 weeks after the implementation of the service. This improvement in waiting times demonstrates the success of the quality improvement project. [Extracted from the article]

A study conducted by researchers at Leiden University Medical Center in the Netherlands examined the association between inflammation in the posterior elements (PE) and facet joint (FJ) and the subsequent development of facet joint ankylosis (FJA) in patients with radiographic axial spondyloarthritis (r-axSpA). The study found that FJ inflammation, although rare in severe r-axSpA, increased the likelihood of developing FJA by over three times compared to FJ without inflammation. This research contributes to the understanding of the relationship between inflammation and ankylosis in patients with axSpA. The study was funded by the Dutch Rheumatism Foundation. [Extracted from the article]

A recent study conducted at Mohammed VI University Hospital in Oujda, Morocco explored the association between trabecular bone score (TBS) and disease parameters in patients with axial spondyloarthritis. The study included 56 patients and found that those with low TBS were older, had higher waist circumference and body mass index, and showed greater clinical activity. However, no association was observed between TBS and vertebral fractures. The research suggests that TBS may be associated with increased bone fragility in patients with active spondyloarthritis. [Extracted from the article]

A recent study conducted by researchers at Southern Medical University in Guangzhou, China, compared lumbar posterior lesions in patients with axial spondyloarthritis (axSpA) and lumbar disc herniation (LDH). The study found that lumbar posterior lesions were more severe in axSpA patients, particularly those with ankylosing spondylitis (AS). These lesions were also found to have diagnostic value in distinguishing axSpA from LDH. The study concluded that lumbar posterior defects were related to adjacent components and did not always follow the same MRI changing pattern as vertebral bodies and sacroiliac joints. [Extracted from the article]

Researchers at University Hospital Center in Faro, Portugal have conducted a study on spondylarthritis (SpA) patients to investigate the association between neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios and disease activity, as well as their predictive value for response to bDMARD treatment. The study included 170 patients, mostly male with an axial phenotype. The results showed significant associations between NLR and PLR with disease activity, and both ratios were found to be significant predictors of therapeutic response to bDMARD in naive SpA patients. This research has been peer-reviewed and provides valuable insights for the treatment of spondylarthritis. [Extracted from the article]

A recent study conducted by researchers from Hospital de Clinicas de Porto Alegre compared two laboratory techniques, flow cytometry (FC) and polymerase chain reaction (PCR), for the detection of HLA-B27 in patients with axial spondyloarthritis (AxSpA). The study involved 62 AxSpA outpatients from a Brazilian University Hospital. The results showed that FC had a sensitivity rate of 98% and an overall accuracy of 85.5%, although its specificity was lower compared to PCR-SSP. The researchers suggest that FC can be a cost-effective option for preliminary screening in clinical practice, especially in low-income regions, and propose an algorithm that combines FC and PCR for optimal resource allocation. [Extracted from the article]

Researchers from Charite University Hospital and School of Medicine in Berlin, Germany have conducted a study on biomarkers for axial spondyloarthritis (axSpA), a type of inflammatory arthritis that primarily affects the spine. The study found that serum levels of certain complement activation proteins, specifically C3dg and MASP-3, were significantly different between axSpA patients and those with chronic low back pain. However, combining these biomarkers with the presence of the HLA-B27 gene variant, which is associated with axSpA, resulted in a loss of sensitivity. The findings suggest that complement activation may play a role in the inflammatory processes and pathogenesis of axSpA. [Extracted from the article]

A new report discusses research findings on rheumatology, specifically focusing on improving the time to diagnosis for axial spondyloarthritis (axSpA). The study was conducted at Ipswich Hospital in the United Kingdom, where they previously did not have an axSpA service. The objective of the study was to develop an axSpA service, establish referral pathways, and raise awareness among health professionals. The researchers audited new suspected axSpA cases and compared data from the first three months of service inception to a year later. They found that the waiting time from initial presentation to diagnosis significantly decreased, indicating an improvement in waiting times for patients. Overall, the study concludes that they have successfully established an axSpA service with clear and standardized pathways. [Extracted from the article]

A recent study conducted by researchers at the University of Bath in the United Kingdom explored the perspectives of individuals living with axial spondyloarthritis (axSpA) and their experiences managing the condition. The study found that optimal self-management of axSpA requires early diagnosis, education, and support from healthcare professionals. Participants emphasized the need for personalized and flexible approaches to self-management, as axSpA is a heterogeneous and unpredictable condition. Additionally, the study highlighted the importance of addressing the invisible nature of axSpA, as individuals often struggle to feel seen and believed due to the lack of visible disability. Coping with fatigue and pain were identified as the most challenging aspects of the condition to manage. The researchers concluded that self-management interventions should target fatigue, pain, and disease acceptance, while also supporting individuals in gaining a deep understanding of their own condition to develop personalized self-care strategies. [Extracted from the article]

New research from the Hospital das Clinicas in Brazil explores the frequency of HLA-B27 positivity in patients with spondyloarthritis (SpA) and its correlation with disease parameters. The study, conducted on a large population of patients from the Brazilian Registry of Spondyloarthritis, found that HLA-B27 positivity was associated with a classic pattern of axial spondyloarthritis (axSpA) similar to that of Caucasian patients worldwide. Conversely, the absence of HLA-B27 was linked to peripheral manifestations and worse outcomes, suggesting phenotypic differences in a diverse population. The findings highlight the importance of considering ethnicity and sex in evaluating clinical and prognostic outcomes in mixed-race populations. [Extracted from the article]

A recent study conducted by Loughborough University in the United Kingdom has found that individuals with Axial Spondyloarthritis (AxSpA) face barriers to physical activity due to vague exercise guidelines and lack of inclusive models. The study surveyed 266 people with AxSpA and found that walking, stretching/flexibility exercises, swimming, weight training, and cycling were the most desired activities. Common barriers to exercise included worries about pain and flare-ups, fatigue, time constraints, cost, lack of knowledge about appropriate activity levels, and limited access to facilities. The study emphasizes the importance of exercise guidance that aligns with individuals' preferences and limitations, as well as the need for outcome assessments of pain, flare frequency, and fatigue. [Extracted from the article]

A researcher from the University of Bath has published new studies and findings in the area of rheumatology, specifically focusing on fatigue in patients with axial spondyloarthritis. The research found that fatigue is a common and debilitating symptom for these patients, and it significantly worsens during flares. The study aimed to determine if there were any significant differences in fatigue scores depending on patients' self-reported flare status. The results showed that fatigue was highest during the middle of a flare, and future studies could further investigate different levels of fatigue associated with different types of flares. This research could help in minimizing the impact of fatigue in patients with axial spondyloarthritis. [Extracted from the article]

A study conducted by researchers at Ruhr-University Bochum in Germany has found that the inclusion of clinical information (CI) improves the accuracy of imaging interpretation for the diagnosis of axial spondyloarthritis (axSpA), a type of musculoskeletal disease. The study involved evaluating imaging sets of 109 patients with suspected axSpA, and found that the precision, specificity, and diagnostic confidence of radiologic evaluation increased when CI was provided. The findings suggest that the inclusion of CI can enhance the accuracy of diagnosing axSpA using radiography and MRI of the sacroiliac joints. [Extracted from the article]

Researchers from the University of Alberta in Canada have developed web-based calibration modules for scoring methods used in the diagnosis of axial spondyloarthritis. The modules, called SPARCC-SIJ RETIC e-tools, provide real-time feedback and assessment of reliability for readers scoring bone marrow edema, inflammation, erosion, and backfill in the sacroiliac joint. The study found that the e-modules were effective in increasing scoring proficiency and are recommended for use in clinical research and trials. The research provides valuable insights into the diagnosis and treatment of musculoskeletal diseases and conditions. [Extracted from the article]

A recent report from Argentina analyzed the clinical, laboratory, and imaging features of men and women with axial spondyloarthritis (axSpA) at the time of diagnosis. The study found that the frequency of axSpA in women was 61.55%. Significant differences were observed between men and women, including a good response to nonsteroidal anti-inflammatory drugs, elevated C-reactive protein, and the presence of bone bridges in magnetic resonance imaging of the sacroiliac joints. The study concluded that women had less radiographic compromise compared to men. This research provides valuable insights into the differences between men and women with axSpA and may contribute to improved diagnosis and treatment strategies. [Extracted from the article]

A recent study conducted at Dr. Soetomo General Academic Hospital in Surabaya, Indonesia aimed to understand the demographic and clinical characteristics of patients with spondyloarthritis (SpA) and its association with disease activity. The study included 38 SpA patients and found that the majority of patients were female with a median age of 48. The patients exhibited moderate disease activity, but no significant correlation was found between disease activity and demographic or clinical parameters. The researchers concluded that further research is needed to better understand the relationship between disease activity and influencing factors. [Extracted from the article]

Researchers at Charite University Hospital and School of Medicine in Berlin, Germany have conducted a review on the role of imaging in the diagnosis and monitoring of axial spondyloarthritis (axSpA), a chronic inflammatory disease that primarily affects the sacroiliac joints and the spine. The review focuses on the significance of new bone formation in axSpA and provides an overview of the characteristic imaging findings of new bone formation in each imaging modality, such as X-ray, MRI, and CT. The researchers emphasize that understanding the significance of new bone formation and its detection using imaging modalities is crucial for the accurate diagnosis and effective management of patients with axSpA. [Extracted from the article]

A new report from the Department of Rheumatology presents data on the treatment of psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), and plaque psoriasis (PsO) with the drug etanercept (ETN). The study aimed to evaluate the effectiveness and safety of ETN in routine clinical practice, particularly for patients who had not reached their treatment goals after 12 weeks. The results showed that extending treatment with ETN beyond 12 weeks was associated with stable or increased rates of remission and low disease activity. Additionally, improvements in symptoms such as pain, fatigue, and depression were observed, and there were no new safety concerns. This research confirms the benefits of continuing ETN treatment and highlights the potential advantages of ETN for these conditions. [Extracted from the article]

A recent study conducted at the University of Hong Kong compared the severity and prevalence of disc degeneration (DD) in patients with axial spondyloarthritis (SpA) and the general population. The study found that SpA patients had lower severity of DD compared to the general population. Male SpA patients and those with longer disease duration had less severe DD. The study also found associations between spinal inflammation, structural changes, mobility, and DD among SpA patients. This research provides valuable insights into the relationship between SpA and disc degeneration. [Extracted from the article]

A recent study conducted at the University Hospital of Bellvitge in Barcelona, Spain, explored the radiographic patterns of the cervical spine, including the zygapophyseal joints, in patients with axial spondyloarthritis (axSpA). The researchers found that evaluating the cervical spine is important in diagnosing and treating axSpA, and that assessing the zygapophyseal joints is particularly significant as it is associated with higher disease activity and worse functionality. The study included 340 patients, with 53.2% of them showing cervical spine involvement. The findings highlight the importance of routine radiographic evaluation of the cervical spine in patients with axSpA. [Extracted from the article]

A research study conducted at Reina Sofia University Hospital in Cordoba, Spain, aimed to evaluate the relationship between biomarkers of inflammation and bone turnover in patients with radiographic and non-radiographic axial spondyloarthritis (axSpA). The study found that patients with radiographic axSpA had decreased levels of a bone formation marker called P1NP, as well as decreased levels of sclerostin, an anti-anabolic bone hormone. Non-radiographic axSpA patients showed increased levels of the inflammatory molecule IL13, which may play a role in preventing inflammation. The study suggests that different inflammatory profiles may contribute to the skeletal features of axSpA patients and further investigation is needed to understand the relationship between inflammation and bone metabolism in this condition. [Extracted from the article]

A recent study conducted at Brigham and Women's Hospital in Boston, Massachusetts, explores the use of single-cell profiling in understanding spondyloarthritis pathogenesis. The study highlights the advancements and emerging trends in single-cell profiling, including sequencing-based approaches for quantifying RNA, protein, and epigenetic modifications. The research emphasizes the potential of single-cell profiling in indexing and characterizing cells, identifying disease-associated cell states, and discovering therapeutic response signatures. However, challenges such as high cost and limited availability of diseased tissue samples still need to be addressed. The study concludes that large-scale collaborative efforts are necessary to fully harness the technical capabilities of single-cell profiling. [Extracted from the article]

A recent study conducted at Vall d'Hebron Hospital in Barcelona, Spain, aimed to identify distinct phenotypes within a broad population of patients with spondyloarthritis (SpA). The researchers used the REGISPONSER registry, which includes data from 31 specialist centers in Spain, and performed a latent class analysis (LCA) to identify the underlying classes of SpA based on predefined clinical and radiographic features. The study identified five latent classes, indicating significant overlap between axial and peripheral phenotypes, supporting a unifying concept of SpA. The presence of psoriasis and related features influenced the phenotype of both axial and peripheral manifestations. [Extracted from the article]

A recent study conducted by researchers at Maastricht University aimed to identify threshold values of presenteeism measurement instruments that reflect an unacceptable work state in employed patients with radiographic axial Spondyloarthritis (r-axSpA). The study also sought to determine whether these thresholds accurately predict future adverse work outcomes (AWO) and evaluate the performance of traditional health outcomes for r-axSpA. The researchers used data from the multinational AS-PROSE study and found that thresholds for measurement instruments for presenteeism and health status have been established, which can help provide work-related support to r-axSpA patients at risk for AWO. [Extracted from the article]

A recent study conducted by researchers at the University of Pisa in Italy focused on axial spondyloarthritis (axSpA), a group of autoimmune diseases that affect the axial skeleton. The study found that in the early stages of the disease, conventional radiology cannot detect the inflammation, but magnetic resonance imaging can, leading to the diagnosis of non-radiographic axSpA (nr-axSpA). The disease progresses to bone reabsorption and abnormal bone deposition, resulting in the ankylosis of the axial skeleton. Peripheral joints can also be affected, with enthesitis being a characteristic manifestation. The study also highlighted the association of axSpA with extra-articular manifestations and comorbidities, which can significantly impact patients' quality of life. The research reviewed literature from 2021 and 2022 to provide an overview of axSpA. [Extracted from the article]

Researchers at Zuyderland Medical Center in the Netherlands have conducted a study on musculoskeletal diseases and conditions, specifically focusing on patients with axial spondyloarthritis (axSpA). The objective of the study was to build a structural model that visualizes and quantifies the interrelationships between different disease outcomes and the Assessment of SpondyloArthritis International Society Health Index (ASAS HI). The study found that disease activity and physical function have a strong impact on ASAS HI, confirming its validity as a measure of overall functioning and health in axSpA patients. This research provides valuable insights into the understanding of disease outcomes and their effects on patients' health. [Extracted from the article]

A recent study conducted by the Amsterdam Rheumatology and Immunology Center ARC has found that there are sex differences in the effectiveness of first-line tumor necrosis factor inhibitors (TNFi) in treating axial spondyloarthritis (axSpA). The study analyzed data from 6,451 axSpA patients who were initiating their first TNFi treatment. The results showed that women had lower treatment response rates and retention rates compared to men. These sex differences were consistent regardless of the outcome measure used for treatment response and became more pronounced over time. [Extracted from the article]

A recent study conducted by researchers at Acibadem University in Istanbul, Turkey, focused on late-onset axial spondyloarthritis (axSpA), a chronic inflammatory disease that affects the sacroiliac joints and spine. The study aimed to expand knowledge of late-onset axSpA and compare its clinical features with early-onset axSpA. The researchers found that late-onset axSpA was more common in females and had a higher incidence of peripheral arthritis and cervical vertebrae involvement compared to early-onset axSpA. Treatment with anti-tumor necrosis factor therapy showed significant improvement in frailty in elderly patients. The study emphasizes the importance of early diagnosis and treatment for axSpA. [Extracted from the article]

A recent report from University Hospital Zurich provides new insights into musculoskeletal diseases and conditions, specifically early axial spondyloarthritis (axSpA). The study aimed to characterize patients fulfilling the ASAS consensus definition of early axSpA and determine the effectiveness of a first tumor necrosis factor inhibitor (TNFi) in early versus established axSpA. The research found that TNFi effectiveness was comparable in early and established disease, suggesting that the treatment is equally effective regardless of disease duration. This information may be valuable for individuals researching musculoskeletal diseases and seeking treatment options. [Extracted from the article]

A recent study conducted at Maastricht University Medical Center in the Netherlands investigated the factors associated with treatment intensification in patients with axial spondyloarthritis (axSpA) and high disease activity (HDA). The study found that treatment intensification was conducted in a minority of patients, and the decision to change treatment was primarily influenced by physician-centered factors, such as physician global assessment (PhGA) and physician-perceived acceptable symptom state (PASS-physician), rather than disease activity or patient perspective. The researchers concluded that further research is needed to better understand these treatment decisions. This information is available in the journal article "Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice" published in Rheumatology. [Extracted from the article]

A study conducted at Singapore General Hospital compared the Assessment of SpondyloArthritis (ASAS) Health Index (HI) scores between patients with radiographic axial spondyloarthritis (r-axSpA) and non-radiographic axial spondyloarthritis (nr-axSpA) in Singapore. The study found that patients with nr-axSpA had poorer overall health and functioning compared to those with r-axSpA. Factors such as higher disease activity, poorer physical function, poorer mental health status, and more depressive symptoms were associated with worse health and functioning. The study provides new insights into the differences between these two types of spondyloarthritis in Singapore. [Extracted from the article]

A recent study conducted by researchers at Chinese University explored the differences in disease courses and treatment responses between male and female patients with spondyloarthritis. The study involved 91 male and 52 female patients who received one year of treatment using a tight control, treat-to-target strategy. The results showed that female patients had lower rates of achieving treatment targets and experienced higher levels of disease burden, functional impairment, and enthesitis compared to male patients. The researchers suggest that further investigation is needed to understand the causes of these differences and potentially develop sex-specific treatment strategies for spondyloarthritis. [Extracted from the article]

A report from Leiden University in the Netherlands discusses the associations between syndesmophytes and facet joint ankylosis (FJA) in patients with radiographic axial spondyloarthritis (r-axSpA). The study aimed to determine if the presence of one lesion increased the risk of the other lesion. The research found that bone formation in vertebrae and facet joints influence each other's occurrence, with syndesmophytes having a larger effect than FJA. This information may be useful for individuals researching musculoskeletal diseases and conditions. [Extracted from the article]

A recently launched clinical trial, NCT06112665, aims to compare the efficacy and safety of tofacitinib versus placebo in treating early active axial spondyloarthritis (axSpA) in patients who have had an inadequate response to at least one nonsteroidal anti-inflammatory drug (NSAID). The study is a phase IV, multicenter, randomized, double-blind, placebo-controlled trial that will last for 16 weeks of treatment and 4 weeks of safety follow-up. The primary outcome measure is the proportion of subjects achieving disease remission at week 16, as defined by the Ankylosing Spondylitis Disease Activity Score (ASDAS)CRP. The trial is not yet recruiting and is estimated to be completed by February 2026. [Extracted from the article]

A recent study from the Universita degli Studi di Milano explores the involvement of bone tissue in rheumatoid arthritis (RA) and spondyloarthritis (SpA). The researchers discuss the complex interactions between bone tissue cells and the immune system, known as osteoimmunology, which play a role in the pathogenesis of these diseases. The study highlights the distinct mechanisms of bone erosion in both RA and SpA, as well as the abnormal bone formation observed in SpA. Additionally, chronic inflammatory arthritis can lead to systemic bone involvement, resulting in bone loss and osteoporosis. [Extracted from the article]

In PsA, remission rates at 6 and 12 months tended to be lowest in cohort A. Response rates were at all time points comparable across cohorts, and less between-cohort disease activity differences were seen at 24 months. Keywords: Glostrup; Denmark; Europe; Rheumatology; Health and Medicine EN Glostrup Denmark Europe Rheumatology Health and Medicine 2781 2781 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Health and Medicine - Rheumatology are presented in a new report. [Extracted from the article]

Keywords: Bone Research; Health and Medicine EN Bone Research Health and Medicine 2867 2867 1 10/24/23 20231027 NES 231027 2023 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on bone research are presented in a new report. Keywords for this news article include: University of Verona, Verona, Italy, Europe, Bone Research, Health and Medicine. [Extracted from the article]

Arthritis, Health and Medicine, Joint Diseases and Conditions, Musculoskeletal Diseases and Conditions Keywords: Arthritis; Health and Medicine; Joint Diseases and Conditions; Musculoskeletal Diseases and Conditions EN Arthritis Health and Medicine Joint Diseases and Conditions Musculoskeletal Diseases and Conditions 3024 3024 1 10/09/23 20231013 NES 231013 2023 OCT 13 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on arthritis are presented in a new report. [Extracted from the article]

Keywords: Amebiasis; Blastocystis; Health and Medicine; Inflammation; Parasitic Diseases and Conditions; Parasitic Intestinal Diseases and Conditions; Protozoan Infections EN Amebiasis Blastocystis Health and Medicine Inflammation Parasitic Diseases and Conditions Parasitic Intestinal Diseases and Conditions Protozoan Infections 6470 6470 1 09/04/23 20230908 NES 230908 2023 SEP 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on blastocystis have been published. On the other hand, PICRUSt analysis in Blastocystis-positive SpA patients showed elevations in pathways that may enhance antioxidant capacities and alleviate intestinal inflammation, while Blastocystis-negative SpA patients showed significant changes in pathways that promote cell division/proliferation and can lead to larger changes in the gut microbiome.". [Extracted from the article]